Post by Leica Biosystems

📗WEEKEND READ: New technologies are transforming how patients are matched to targeted cancer treatments—but what will it take to keep that momentum going? Rob Monroe, MD, PhD, Chief Medical Officer at Leica Biosystems, shares his insights with Technology Networks. “Technologies such as multiplexing, spatial profiling, and artificial intelligence (AI) are already proving to be potentially game-changing in research settings. To successfully integrate these tools into companion diagnostics that meaningfully change the prognosis for cancer patients will require unprecedented collaboration between drug developers, technology innovators, and regulators.” Read more of his insights in "Optimizing the Next Generation of Targeted Cancer Treatments" here: https://ow.ly/2h1A50YemOk #DanaherNews #AI #Multiplexing #CancerResearch